HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Port, S. C. Search for Related Content PubMed PubMed Citation Articles by Port, S. C.

The Role of Radionuclide Ventriculography in the Assessment of Prognosis in Patients with CAD

Cardiology Department, Mount Sinai Medical Center, Milwaukee, Wisconsin

Correspondence: For correspondence or reprints contact: Steven C. Port, MD, Cardiology Department, Mount Sinai Medical Center, 950 North 12th St., Milwaukee, WI 53233.

ABSTRACT

One of the most important roles of cardiovascular nuclear medicine in evaluating patients with coronary artery disease (CAD) is predicting patient outcome. Measurements of ventricular function obtained by radionuclide ventriculography play a key role in defining a patient's prognosis. Because ventricular function correlates well with the total extent of myocardial ischemic burden, data derived from radionuclide ventriculography serve as valuable prognostic indicators. Radionuclide ventriculography provides noninvasive information that is comparable to contrast angiography for predicting subsequent cardiac events and mortality in patients with CAD.

Key Words: coronary artery disease • radionuclide ventriculography • prognosis

FOOTNOTES

This paper was presented in part at the Annual Meeting of the Society of Nuclear Medicine on June 9, 1993, as part of a Continuing Medical Education Seminar organized by the Cardiovascular Council.